* iRhythm Technologies Inc IRTC.OQ reported a quarterly
adjusted
loss of 65 cents per share for the quarter ended in June,
lower than the same quarter last year, when the company reported
EPS of -61 cents. The mean expectation of twelve analysts for
the quarter was for a loss of 89 cents per share. Wall Street
expected results to range from $-1.05 to -78 cents per share.
* Revenue rose 19.3% to $148.05 million from a year ago;
analysts
expected $146.21 million.
* iRhythm Technologies Inc's reported EPS for the quarter
was a
loss of 65 cents.
* The company reported a quarterly loss of $20.11 million.
* iRhythm Technologies Inc shares had fallen by 19.9% this
quarter and lost 19.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 6.7%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 12 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is "buy."
Wall Street's median 12-month price target for iRhythm
Technologies Inc is $133.00
This summary was machine generated from LSEG data August 1 at
09:00 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.89 -0.65 Beat
Mar. 31 2024 -0.96 -1.23 Missed
Dec. 31 2023 -0.59 -1.26 Missed
Sep. 30 2023 -0.64 -0.89 Missed